Skip to main
THC

Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare (THC) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 60%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

Tenet Healthcare demonstrated robust financial performance in the third quarter, with consolidated net operating revenue reaching $5.3 billion and a 12% year-over-year increase in adjusted EBITDA to $1.1 billion, reflecting a solid margin of 20.8%. The company's Hospital segment showed positive trends, highlighted by a 1.4% growth in adjusted admissions and a 5.9% rise in revenue per adjusted admission, driven by a favorable payor mix and higher-acuity cases, leading to improved margins. Management's raised revenue guidance for the year and anticipated growth in both hospital and ambulatory surgery center segments further underpin a positive outlook on Tenet Healthcare’s stock.

Bears say

Tenet Healthcare is facing a negative outlook primarily due to its underperformance in EBITDA growth compared to peers, with a modest $50 million raise in Q3 2025 that falls short of expectations and industry benchmarks. Furthermore, the company’s leverage indicates a risky balance sheet, compounded by significant exposure to government-sponsored reimbursement programs and geographic concentration risks. Additionally, potential adverse shifts in payer mix could lead to increased volatility in operating trends, further exacerbating the company's financial challenges.

Tenet Healthcare (THC) has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 60% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tenet Healthcare (THC) Forecast

Analysts have given Tenet Healthcare (THC) a Buy based on their latest research and market trends.

According to 15 analysts, Tenet Healthcare (THC) has a Buy consensus rating as of Dec 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $230.13, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $230.13, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tenet Healthcare (THC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.